RECURRENT PROSTATE CANCER: DECISION SUPPORT GUIDE

描述：每年约有179，000名男性被诊断患有前列腺癌。 早期诊断和治疗有所增加;然而，这些男性中的很大一部分（30%-75%）将在10年内显示PSA水平上升。 可以采取额外的治疗来延缓癌症的生长和扩散，但与最初的诊断和治疗一样，没有明确的治疗方法，而且所有的治疗方法都有副作用。 患有复发性前列腺癌的男性及其家人需要信息和工具来帮助他们在这个阶段。 前列腺癌的早期症状决策支持指南CD-ROM将是一个交互式决策支持系统，将帮助患者及其家人与他们的医疗团队一起参与治疗决策过程。 在第一阶段，我们将确定复发性前列腺癌男性及其家庭成员需要的治疗信息和问题。 我们还将与这些人及其家人合作，确定互动方法和工具，并详细开发一个信息领域和一组个人问题，以纳入原型产品。 此外，将对原型进行测试，并将完成第二阶段开发的完整光盘的内容规格。

DESCRIPTION: Approximately 179,000 men are diagnosed with prostate cancer each year. Early stage diagnosis and treatment has risen; however, a significant portion of these men (30%-75%) will show a rise in PSA levels within 10 years. Additional treatment can be instituted to retard the growth and spread of the cancer, but as with initial diagnosis and treatment, no definitive treatments exist and all carry side effects. Men with recurrent prostate cancer and their families need information and tools to assist them at this stage. The Recurrent Prostate Cancer: A Decision Support Guide CD-ROM will be an interactive decision support system that will assist the patient and his family in participating with their healthcare team in the treatment decision process. In Phase I, we will identify the treatment information and issues that men with recurrent prostate cancer and their family members need. We will also work with these men and their families to identify interactive methods and tools, as well as develop in detail, one area of information and one set of personal issues for inclusion in the prototype product. Additionally, the prototype will be tested and the content specifications for the full CD-ROM, to be developed in Phase II, will be completed.